What is the evaluation and treatment approach for meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Treatment of Acute Meningitis

Immediate Priorities: The First Hour

All patients with suspected meningitis require immediate stabilization of airway, breathing, and circulation, followed by blood cultures and empiric antibiotics within 1 hour of hospital arrival, with lumbar puncture performed urgently unless contraindicated. 1

Initial Assessment and Triage

  • Document Glasgow Coma Scale score immediately upon arrival for prognostic value and to monitor deterioration 1
  • Calculate National Early Warning Score: aggregate score ≥5-6 requires urgent senior clinician review; score ≥7 requires critical care assessment 1
  • Record presence or absence of rash, fever, headache, altered mental status, neck stiffness, seizures, and any signs of shock (hypotension, poor capillary refill, cold extremities) 1
  • Do not rely on Kernig's or Brudzinski's signs for diagnosis as they have variable sensitivity and specificity 1, 2
  • Senior consultant review should occur much earlier than the standard 14-hour timeframe, as patients can deteriorate rapidly 1

Critical Care Criteria

Transfer to critical care is indicated for 1:

  • Rapidly evolving rash
  • GCS ≤12 (or drop of >2 points)
  • Uncontrolled seizures
  • Evidence of severe sepsis or septic shock
  • Need for organ support or hemodynamic monitoring

Intubation should be strongly considered for GCS <12 1

Diagnostic Approach

Indications for CT Before Lumbar Puncture

Perform cranial imaging before LP only if 1:

  • GCS ≤12 (though LP may be safe at levels below this)
  • Focal neurological signs
  • Papilloedema present
  • Continuous or uncontrolled seizures
  • Severe immunocompromised state

Critical pitfall: Inability to visualize the fundus is NOT a contraindication to LP, especially with short symptom duration 1

Lumbar Puncture Timing

For patients with suspected meningitis WITHOUT shock or severe sepsis 1:

  • Perform LP within 1 hour of hospital arrival if safe
  • Start treatment immediately after LP (within first hour)
  • If LP cannot be performed within 1 hour, start antibiotics immediately after blood cultures and perform LP as soon as possible thereafter

For patients with predominantly sepsis or rapidly evolving rash 1:

  • Give antibiotics immediately after blood cultures
  • Start fluid resuscitation with 500 mL crystalloid bolus
  • Follow Surviving Sepsis guidelines
  • Do NOT perform LP at this time

CSF Interpretation

Best diagnostic parameter: CSF leukocyte count (area under curve 0.95) 1, 3

Typical bacterial meningitis findings 3:

  • WBC count: 1,000-5,000 cells/mm³ (range 100-110,000)
  • Neutrophil predominance: 80-95%
  • CSF glucose <40 mg/dL (in 50-60% of cases)
  • CSF:serum glucose ratio <0.4
  • Elevated protein

Microbiological Confirmation

  • CSF Gram stain: 60-90% sensitivity, 97% specificity (correlates with bacterial concentration) 3
  • CSF culture: Positive in 70-85% of untreated patients 3
  • CSF PCR: 87-100% sensitivity, 98-100% specificity; remains positive even after antibiotic administration 4
  • Blood cultures should be obtained within 1 hour of arrival 1

Partially Treated Meningitis

Critical consideration: Antibiotic pretreatment significantly alters diagnostic yield 4:

  • Gram stain sensitivity decreases by ~20%
  • CSF cultures may sterilize within 2 hours for meningococci, 4 hours for pneumococci
  • CSF WBC, glucose, and protein remain abnormal and reliable
  • CSF PCR remains highly sensitive and should be utilized 4

Common pitfall: Do not assume viral meningitis based solely on lymphocytic predominance in CSF, as partially treated bacterial meningitis can present this way 4

Empiric Antibiotic Treatment

Treatment Must Begin Within 1 Hour

Antibiotics should be administered within 1 hour of hospital arrival, regardless of whether CT or LP has been performed 1. Delays in antibiotic administration increase mortality 1.

Empiric Regimens by Age

Adults <60 years 1:

  • Preferred: Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours
  • Alternative: Chloramphenicol 25 mg/kg IV every 6 hours
  • Add vancomycin 15-20 mg/kg IV every 12 hours OR rifampicin 600 mg IV/PO every 12 hours if penicillin-resistant pneumococci suspected (e.g., recent arrival from high-resistance region) 1

Adults ≥60 years 1:

  • Preferred: Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours PLUS Amoxicillin 2g IV every 4 hours (for Listeria coverage)
  • Alternative: Chloramphenicol 25 mg/kg IV every 6 hours AND Co-trimoxazole 10-20 mg/kg (trimethoprim component) in 4 divided doses
  • Add vancomycin or rifampicin if resistance suspected

Pediatric patients with meningitis 5:

  • Initial dose: 100 mg/kg IV (not to exceed 4 grams)
  • Maintenance: 100 mg/kg/day (not to exceed 4 grams daily), given once daily or divided every 12 hours
  • Duration: 7-14 days typically

Neonates 5:

  • Administer IV doses over 60 minutes (not 30 minutes) to reduce risk of bilirubin encephalopathy
  • Ceftriaxone contraindicated in premature neonates and in neonates ≤28 days requiring calcium-containing IV solutions

Pathogen-Specific Treatment

Streptococcus pneumoniae 1

Penicillin-sensitive (MIC ≤0.06 mg/L):

  • Benzylpenicillin 2.4g IV every 4 hours OR
  • Ceftriaxone 2g IV every 12 hours OR
  • Cefotaxime 2g IV every 6 hours
  • Duration: 10 days if stable; up to 14 days if slow response

Penicillin-resistant but cephalosporin-sensitive:

  • Continue ceftriaxone or cefotaxime
  • Duration: 10-14 days

Penicillin AND cephalosporin resistant:

  • Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours PLUS
  • Vancomycin 15-20 mg/kg IV every 12 hours PLUS
  • Rifampicin 600 mg IV/PO every 12 hours
  • Duration: 14 days

Neisseria meningitidis 1

  • Preferred: Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours
  • Alternative: Benzylpenicillin 2.4g IV every 4 hours OR Chloramphenicol 25 mg/kg IV every 6 hours
  • If not treated with ceftriaxone: Give single dose ciprofloxacin 500 mg PO for eradication 1
  • Duration: 5 days if recovered

Listeria monocytogenes 1

  • Preferred: Amoxicillin 2g IV every 4 hours
  • Alternative: Co-trimoxazole 10-20 mg/kg (trimethoprim component) in 4 divided doses
  • Duration: 21 days

Haemophilus influenzae 1

  • Preferred: Cefotaxime 2g IV every 6 hours
  • Alternative: Moxifloxacin 400 mg IV/PO once daily
  • Duration: 10 days

Adjunctive Dexamethasone Therapy

Dexamethasone should be administered to children and adults with suspected bacterial meningitis before or at the time of antibiotic initiation 2. The evidence is strongest for:

  • Adults with pneumococcal meningitis (reduces mortality and adverse outcomes) 6
  • Children with H. influenzae type B meningitis 6

Dexamethasone must be given concomitant with or just prior to the first antimicrobial dose for maximal effect on subarachnoid space inflammation 6.

Supportive Care and Hemodynamic Management

Fluid Management 1

  • Keep patients euvolemic to maintain normal hemodynamic parameters
  • Do NOT restrict fluids in attempt to reduce cerebral edema
  • Crystalloids are initial fluid of choice
  • Consider albumin for persistent hypotensive shock despite corrective measures

Vasopressor Support 1

  • Target mean arterial pressure (MAP) ≥65 mmHg (individualize based on age and cerebral edema presence)
  • Norepinephrine is the vasopressor of choice (equivalent efficacy to dopamine with fewer adverse events)
  • Consider hydrocortisone 200 mg once daily for persisting hypotensive shock

Seizure Management 1

  • Treat suspected or proven seizures early
  • Perform EEG monitoring for suspected status epilepticus (including non-convulsive status) in patients with fluctuating GCS off sedation

Intracranial Pressure Management 1

  • Basic measures to control ICP and maintain cerebral perfusion pressure for suspected/proven raised ICP
  • Routine ICP monitoring is NOT recommended

Complications and Follow-Up

Common Neurologic Complications 1

  • Hearing loss (34% in children, 5-35% overall)
  • Seizures (13%)
  • Motor deficits (12%)
  • Cognitive defects (9%)
  • Hydrocephalus (7%)
  • Visual loss (6%)

Mandatory Follow-Up 1

Hearing assessment:

  • Perform during admission (otoacoustic emission screening in children; speech tone audiometry in adults)
  • Repeat if initial test abnormal or clinical suspicion develops
  • Early cochlear implant consideration prevents speech development delays in children

Neuropsychological evaluation:

  • Indicated for patients with cognitive complaints post-discharge
  • One-third of survivors have persisting complaints

Key Pitfalls to Avoid

  1. Never delay antibiotics while awaiting CT or LP—start treatment within 1 hour regardless 1, 4
  2. Do not falsely reassure based on low early warning scores—patients deteriorate rapidly 1
  3. Do not assume viral meningitis based on lymphocytic CSF in partially treated cases 4
  4. Do not discontinue antibiotics based on negative cultures alone if CSF parameters and clinical presentation suggest bacterial meningitis with prior antibiotic exposure 4
  5. Do not use latex agglutination tests as they are surpassed by PCR 4
  6. Do not forget Listeria coverage in patients ≥60 years 1
  7. Do not administer ceftriaxone to neonates receiving calcium-containing IV solutions 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Coding for Bacterial Meningitis Based on Lumbar Puncture Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpretation and Management of Partially Treated Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.